Pethidine Hcl Fresenius
Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate
Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 4058.
Registration
- Applicants
- 1
- Registrations
- 3
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Fresenius Kabi Manufacturing SA (Pty) Ltd | Pethidine HCL fresenius | 25 mg/1 ml, 50 mg/1 ml, 100 mg/2 ml | B0925, B0928, B1630 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Pethidine HCL 50 mg/1 ML fresenius EACH 1,0 ml AMPOULE CONTAINS PETHIDINE HYDROCHLORIDE 50,0 mg | 50 mg/1 ml | B0925B/2.9/925 | Registered | Not determined | None |
| Pethidine HCL 25 mg/1 ML fresenius EACH 1 ml AMPOULE CONTAINS PETHIDINE HYDROCHLORIDE 25 mg | 25 mg/1 ml | B0928B/2.9/928 | Registered | Not determined | None |
| Pethidine HCL 100 mg/2 ML fresenius EACH 2 ml AMPOULE CONTAINS PETHIDINE HYDROCHLORIDE 100 mg | 100 mg/2 ml | B1630B/2.9/1630 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S6: Pethidine
- pethidine-intermediate A, pethidine-intermediate B and pethidine-intermediate C.
Consolidated Schedules 06 July 2026, line 10371
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.